|
| |
|
| Year : 1989 | Volume
: 35
| Issue : 1 | Page : 3-8 |
Centbutindole vs trifluoperazine : a double-blind controlled clinical study in acute schizophrenia.
DR Doongaji, RS Satoskar, AS Sheth, JS Apte, AB Desai, BR Shah
Correspondence Address:
D R Doongaji
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 0002685263 
Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.
[FULL TEXT] [PDF Not available]*
|
